论文部分内容阅读
作者在同时期内对150例慢性乙型肝炎分别以低剂量干扰素(100万单位/日)、猪苓多糖合乙肝疫苗、胸腺因子D进行治疗,疗程均为三个月。三组药物均有较好的降ALT、SB和改善白球蛋白比例的作用。同时均有一定的抑制HBV复制的作用。干扰素、猪苓多糖、胸腺因子D三组的HBVDNA阴转率分别为54.6％、48.6％、25％;HBeAg的阴转率分别为57.7％、46.2％、26.7％;三组的HBeAg、HBVDNA、抗HBcIgM三项全部阴转分别为17.2％、26.3％、14.8％,说明均不能达到理想的抑制病毒的效果。
During the same period, the authors treated 150 patients with chronic hepatitis B with low-dose interferon (1 million units / day), Polyporus umbellatus polysaccharide combined with hepatitis B vaccine, and thymus factor D for three months respectively. The three groups of drugs have a better reduction of ALT, SB and improve the role of white globulin ratio. At the same time have a certain effect of inhibiting HBV replication. The negative conversion rates of HBVDNA were 54.6%, 48.6% and 25% respectively for interferon, Polyporus umbellatus polysaccharide and Thymus D group. The negative conversion rates of HBeAg were 57.7%, 46.2% and 26.7% respectively. The HBeAg, HBVDNA , Anti-HBcIgM three all negative were 17.2%, 26.3%, 14.8%, indicating that they can not achieve the desired effect of inhibiting the virus.